Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

BerGenBio - Filing #2542730

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
431,000 NOK
43,000 NOK
Current assets
173,904,000 NOK
166,663,000 NOK
Non-current liabilities
0 NOK
275,000 NOK
Current liabilities
46,859,000 NOK
77,933,000 NOK
Revenue
354,000 NOK
389,000 NOK
Profit (loss)
0 NOK
0 NOK
190,401,000 NOK
190,401,000 NOK
0 NOK
0 NOK
302,122,000 NOK
302,122,000 NOK
0 NOK
0 NOK
Comprehensive income
0 NOK
0 NOK
189,234,000 NOK
189,234,000 NOK
0 NOK
0 NOK
302,606,000 NOK
302,606,000 NOK
0 NOK
0 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.